Axsome Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.578; its P/E ratio is -13.43; Axsome Therapeutics is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-1.30. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 24.37M	$ 16.85M	$ 8.82M	$ 0.00	$ 0.00
Gross Profit	$ 22.08M	$ 14.92M	$ 7.84M	-	-
EBIT	$ -59.92M	$ -42.41M	$ -39.18M	$ -38.29M	$ -32.61M
EBITDA	$ -57.90M	$ -40.45M	$ -37.91M	$ -37.98M	$ -32.30M
Net Income Common Stockholders	$ -61.24M	$ -44.82M	$ -41.44M	$ -39.63M	$ -33.98M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 200.84M	$ 227.52M	$ 73.39M	$ 84.71M	$ 86.47M
Total Assets	$ 331.48M	$ 338.96M	$ 180.56M	$ 88.56M	$ 87.79M
Total Debt	$ 94.68M	$ 94.33M	$ 94.17M	$ 50.28M	$ 49.71M
Net Debt	$ -106.16M	$ -133.19M	$ 20.77M	$ -34.43M	$ -36.76M
Total Liabilities	$ 221.92M	$ 181.60M	$ 165.36M	$ 73.86M	$ 72.15M
Stockholders Equity	$ 109.56M	$ 157.36M	$ 15.20M	$ 14.70M	$ 15.63M
Cash Flow	-
Free Cash Flow	$ -27.74M	$ -22.82M	$ -33.78M	$ -32.87M	$ -28.84M
Operating Cash Flow	$ -27.56M	$ -22.76M	$ -33.54M	$ -32.65M	$ -28.84M
Investing Cash Flow	$ -180.86K	$ -66.06K	$ -53.24M	$ -213.74K	$ 0.00
Financing Cash Flow	$ 1.07M	$ 176.95M	$ 75.46M	$ 31.10M	$ 690.48K

Currency in USD

Axsome Therapeutics Earnings and Revenue History

Income Statement >

Axsome Therapeutics Debt to Assets

Balance Sheet >

Axsome Therapeutics Cash Flow

Cash Flow >

Axsome Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing